Thomas Denize
Impact in
- Health Informatics top 5%
- Artificial Intelligence in Healthcare and Education
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 15
- Lung Cancer Research Studies 4
-
- Renal cell carcinoma treatment 13
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Sabina Signoretti (10 shared papers)Cécile Badoual (7 shared papers)Isaac S. Kohane (1 shared paper)Emily Walton (4 shared papers)Kun‐Hsing Yu (1 shared paper)Jeffrey Alan Golden (1 shared paper)Eliana Marostica (1 shared paper)Éric Tartour (4 shared papers)
- Journals
- Clinical Cancer Research (5 papers)Cancer Cell (3 papers)Nature Communications (2 papers)Human Pathology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Thomas Denize
35 papers receiving 1.8k citations
Thomas Denize's Hit Papers
Peers
Comparison fields: 5 of 80
- Health Informatics 62
- Oncology 570
- Pulmonary and Respiratory Medicine 648
- Otorhinolaryngology 60
- Cancer Research 133
Countries citing papers authored by Thomas Denize
This map shows the geographic impact of Thomas Denize's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Denize with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Denize more than expected).
Fields of papers citing papers by Thomas Denize
This network shows the impact of papers produced by Thomas Denize. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Denize. The network helps show where Thomas Denize may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Denize, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma Hit paper breakdown → | 2021 | 443 |
| 2 | Progressive immune dysfunction with advancing disease stage in renal cell carcinoma Hit paper breakdown → | 2021 | 368 |
| 3 | A pathology foundation model for cancer diagnosis and prognosis prediction Hit paper breakdown → | 2024 | 314 |
| 4 | 2022 | 88 | |
| 5 | 2022 | 66 | |
| 6 | 2021 | 54 | |
| 7 | 2018 | 51 | |
| 8 | 2023 | 48 | |
| 9 | 2022 | 33 | |
| 10 | 2018 | 32 | |
| 11 | 2022 | 27 | |
| 12 | 2023 | 27 | |
| 13 | 2023 | 26 | |
| 14 | 2021 | 23 | |
| 15 | 2023 | 23 | |
| 16 | 2023 | 23 | |
| 17 | 2025 | 22 | |
| 18 | 2020 | 21 | |
| 19 | 2021 | 17 | |
| 20 | 2022 | 17 |
About Thomas Denize
Thomas Denize is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Cancer Research and Artificial Intelligence, having authored 40 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Renal cell carcinoma treatment (13 papers), Lung Cancer Research Studies (4 papers), Head and Neck Cancer Studies (3 papers), AI in cancer detection (3 papers), Cervical Cancer and HPV Research (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Health Informatics (62 citations), Oncology (570 citations), Pulmonary and Respiratory Medicine (648 citations), Otorhinolaryngology (60 citations) and Cancer Research (133 citations). Thomas Denize has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Sabina Signoretti, Cécile Badoual, Isaac S. Kohane, Emily Walton, Kun‐Hsing Yu, Jeffrey Alan Golden, Eliana Marostica, Éric Tartour, H. Mirghani and Jérémy Augustin. Their work appears in journals such as Clinical Cancer Research, Cancer Cell, Nature Communications, Human Pathology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.